OUR STORY
From university research to a new generation of implantable sensing solutions.
WHO WE ARE
FORESEE MedTech is a medical technology spin-off of Universitat Pompeu Fabra (UPF), based in Barcelona, Spain.
We are developing an innovative intravascular microsensing platform designed to provide more comprehensive physiological monitoring for patients living with heart failure.
Our mission is to combine scientific innovation, advanced engineering, and clinical needs to develop reliable and scalable implantable monitoring technology.
OUR SCIENTIFIC ORIGINS
FORESEE builds on research at Universitat Pompeu Fabra in bioelectrical phenomena, wireless power transfer, and communication through volume conduction.
Scientific work led by Prof. Antoni Ivorra established the foundations of the technology, which subsequently progressed through European Research Council projects and translational research activities.
FORESEE was established to advance this scientific foundation towards a new generation of implantable medical technologies.
The eAXON project established scientific foundations for volume-conduction-based implantable technologies.
Explored the potential of eAXON technology for implantable sensing applications.
€2.5 million in competitive European funding supporting technology maturation and validation.
Establishment of FORESEE MedTech as a Universitat Pompeu Fabra (UPF) spin-off to translate the technology into a multiparametric implantable medical platform.